Diabetes Typ 2 I Ist Typ 2 Diabetes durch Ernährung heilbar? I Folge 3 I Prophylabs by UKSH

Can diabetes be cured through diet? This claim is frequently published in the media. In this episode, Prof. Sina, Head of Nutritional Medicine at the University Hospital Schleswig-Holstein (UKSH) in Lübeck, presents a real bombshell from recent research on the treatment of type 2 diabetes and answers the question of whether type 2 diabetes can be cured through diet. DISCLAIMER The content of these videos is not suitable for self-diagnosis and should only serve as support for general well-being. It does not constitute medical treatment for any disease*. *Legal Notice: The content on our YouTube channel "Prophylabs" is provided by experts in the field of nutritional medicine and is intended for informational purposes. The information presented on our channel does not replace a medical diagnosis or treatment. Please always seek the advice of a qualified healthcare provider if you have health problems or concerns. The information provided on our channel is subject to change without notice and is not binding. We assume no liability for damages resulting from the use of the information provided on our channel. *Legal Notice: The content on our YouTube channel "Prophylabs" is provided by experts in the field of nutritional medicine and is intended for informational purposes only ... Episode overview: 1:58 - What comes after the low-calorie phase? 2:36 - What does remission mean? 4:15 - How are obesity and type 2 diabetes related? 4:26 - Visceral adipose tissue and insulin resistance 7:24 - Alternatives if low-calorie diets are unsuccessful 9:32 - Contents of a nutritional consultation 12:29 - Conclusion Sources: 1. Source Minute 00:15 Skurk T. et al. (2021). Recommendations for the nutrition of people with type 2 diabetes. Diabetology and Metabolism, 16 (S 02), S255-S289 2. Source Minute 00:42 Ej Lean M. et al. (2018). Primay care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet, 391 (10120):541-551